Redefining non-inferiority in anamnestic antibody responses using the mean increase of log-transformed antibody titers after revaccination: Secondary analysis of a randomized controlled rabies vaccination trial

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Non-inferiority in the anamnestic antibody response is conventionally determined by comparing seroconversion rates after revaccination. However, this approach is inadequate in the case of high pre-booster antibody titers. Therefore, we propose an alternative method to determine non-inferiority of booster responses. We used anonymized data from a randomized controlled trial (NCT01388985; EudraCT 2011-001612-62) in 500 adults, comparing a two-visit primary vaccination schedule (two intradermal 0.1 mL rabies vaccine doses on day 0 and 7) with a three-visit schedule (single intradermal 0.1 mL dose on day 0, 7, and 28). Participants were revaccinated intradermally (single dose) 1 to 3 years later. Rabies virus neutralizing antibody titers were measured on day 0 and 7 after revaccination. After log3-transformation of antibody titers, the mean increase in titers after revaccination was compared between schedules. Non-inferiority was defined as the lower bound of the two-sided 95% confidence interval not exceeding −0.369. Four hundred and ten participants fulfilled the inclusion criteria. The mean increase in log3 titer was 2.21 and 2.31 for the two-visit and three-visit schedule, respectively. The difference between these increases was −0.10 [−0.28, 0.08], meeting the non-inferiority criterion. In conclusion, comparing mean increases in log-transformed titers after revaccination appears to be a feasible and more informative method of studying non-inferiority regarding the anamnestic antibody response.

Cite

CITATION STYLE

APA

Overduin, L. A., Soentjens, P. H. P., Goeman, J. J., Berkowska, M. A., van Dongen, J. J. M., & Visser, L. G. (2020). Redefining non-inferiority in anamnestic antibody responses using the mean increase of log-transformed antibody titers after revaccination: Secondary analysis of a randomized controlled rabies vaccination trial. Vaccines, 8(4), 1–11. https://doi.org/10.3390/vaccines8040721

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free